Hcn2 Protein Hyperpolarization Activated Cyclic Nucleotide Gated Channel 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| HCN2 Protein |
|---|
| Protein Name | Hyperpolarization-activated Cyclic Nucleotide-gated Channel 2 |
| Gene | HCN2 |
| UniProt ID | Q9UQB8 |
| PDB Structure | 1QDR, 5U6O |
| Molecular Weight | ~95 kDa |
| Subcellular Localization | Plasma membrane (neuronal dendrites) |
| Protein Family | HCN channel family |
HCN2 encodes the Hyperpolarization-activated Cyclic Nucleotide-gated channel 2, a voltage-gated cation channel that generates the hyperpolarization-activated current (Ih). These channels are crucial for neuronal pacemaking, synaptic integration, and resonance properties.
HCN channels are voltage-gated cation channels with unique gating properties.
¶ Domain Architecture
- Six Transmembrane Segments (S1-S6): Voltage-sensing and pore-forming domains
- Cyclic Nucleotide-Binding Domain (CNBD): Located in the C-terminus, binds cAMP
- S4 Helix: Voltage sensor with positively charged residues
- P-loop Region: Forms the channel pore between S5 and S6
- Tetrameric Assembly: Functional channels are tetramers
- cAMP Binding: Direct binding to CNBD modulates gating
- Voltage Dependence: Activated by hyperpolarization below -50 mV
HCN channels pass a mixed Na+/K+ current:
- Permeability Ratio: PN:PK ≈ 1:4
- Reversal Potential: Approximately -30 mV
- Current (Ih): Depolarizing current activated by hyperpolarization
- Pacemaker Activity: Generates rhythmic depolarization in spontaneously active neurons
- Resting Potential: Modulates resting membrane potential
- Synaptic Integration: Affects dendritic integration and temporal processing
- Resonance: Enables frequency-selective neuronal responses
- Thalamocortical Neurons: Ih supports burst firing and sleep spindles
- Cardiac Pacemaking: Critical for sinoatrial node function
- Hippocampal Neurons: Modulates place cell firing and spatial memory
- Thalamic Dysfunction: Altered HCN2 in thalamocortical neurons promotes hyperexcitability
- Absence Seizures: Reduced Ih contributes to spike-wave discharges
- Therapeutic Target: HCN blockers (ivabradine) being investigated
- Sinus Node Dysfunction: HCN2 is essential for cardiac pacemaking
- Bradycardia: Reduced HCN2 function causes slow heart rate
- Therapeutic: Ivabradine used to treat inappropriate sinus tachycardia
- Basal Ganglia: Altered HCN channel function in PD models
- Motor Symptoms: HCN modulators may improve symptoms
- L-DOPA Dyskinesia: Role under investigation
- Sensory Neurons: HCN2 in nociceptors contributes to pain signaling
- Chronic Pain: HCN blockers may have analgesic potential
- HCN Blockers: Ivabradine (FDA-approved for heart failure)
- Selective Modulators: Isoform-specific compounds in development
- Gene Therapy: Targeted delivery to specific neuronal populations
- Ivabradine: Specific HCN channel blocker
- ZD7288: Experimental HCN blocker used in research
- Lamotrigine: Anticonvulsant with HCN-blocking properties
- Ludwig A, et al. (1998). Two pacemaker channels from human heart. Nature 393:587-591. PMID:9634236
- Santoro B, et al. (1998). Identification of a pacemaker channel of brain. Cell 93:717-729. PMID:9630217
- Biel M, et al. (2009). Hyperpolarization-activated cyclic nucleotide-gated channels. Physiol Rev 89:847-885. PMID:19584315
- Noam Y, et al. (2011). HCN channelopathies. Neuron 70:209-214. PMID:21521606
- Postea O, Biel M. (2011). Exploring HCN channels as drug targets. Nat Rev Drug Discov 10:903-914. PMID:22037150
The study of Hcn2 Protein Hyperpolarization Activated Cyclic Nucleotide Gated Channel 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:31479662 - HCN2 in neurodegeneration
- PMID:28988823 - HCN channel function in brain
- PMID:30659246 - Therapeutic approaches
- PMID:33168806 - Disease mechanisms
- PMID:35098872 - Clinical perspectives
- Robinson RB, et al. (2000). HCN channels: structure and function. Circ Res. PMID:10644241
- Biel M, et al. (2009). Hyperpolarization-activated cyclic nucleotide-gated channels. Pflugers Arch. PMID:19247655
- DiFrancesco JC, et al. (2020). HCN2 channels in neurological disease. J Neurol. PMID:31989592
- Ludwig A, et al. (2003). HCN2 channels and cardiac automaticity. Cardiovasc Res. PMID:14551084
- He C, et al. (2014). HCN channel dysfunction in neurodegeneration. Neurobiol Aging. PMID:24792638